{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:06:19Z","timestamp":1790885179044,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.mam.2024.101318","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T19:14:41Z","timestamp":1725995681000},"page":"101318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Immunomodulation: A new approach to cancer cachexia, potentially suitable for aging"],"prefix":"10.1016","volume":"100","author":[{"given":"Fabio","family":"Penna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Rubini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Costelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mam.2024.101318_bib1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cellsig.2016.01.010","article-title":"Transforming growth factor type beta (TGF-\u03b2) requires reactive oxygen species to induce skeletal muscle atrophy","volume":"28","author":"Abrigo","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.mam.2024.101318_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2063179","article-title":"Role of oxidative stress as key regulator of muscle wasting during cachexia","volume":"2018","author":"\u00c1brigo","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10712-0","article-title":"Skeletal muscle PGC-1\u03b11 reroutes kynurenine metabolism to increase energy efficiency and fatigue-resistance","volume":"10","author":"Agudelo","year":"2019","journal-title":"Nat. Commun."},{"issue":"7814","key":"10.1016\/j.mam.2024.101318_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.mam.2024.101318_bib5","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jcsm.12402","article-title":"Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review","volume":"10","author":"Anker","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"11","key":"10.1016\/j.mam.2024.101318_bib7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"16","key":"10.1016\/j.mam.2024.101318_bib8","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1042\/BCJ20170032","article-title":"Novel targeted therapies for cancer cachexia","volume":"474","author":"Argil\u00e9s","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.mam.2024.101318_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nut.2019.03.012","article-title":"Mediators of cachexia in cancer patients","volume":"66","author":"Argil\u00e9s","year":"2019","journal-title":"Nutrition"},{"issue":"7971","key":"10.1016\/j.mam.2024.101318_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","article-title":"CAR T therapy beyond cancer: the evolution of a living drug","volume":"619","author":"Baker","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-64282-z","article-title":"An elevated neutrophil-to-lymphocyte ratio associates with weight loss and cachexia in cancer","volume":"10","author":"Barker","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib12","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1038\/s41467-023-37595-6","article-title":"NAD+ repletion with niacin counteracts cancer cachexia","volume":"14","author":"Beltr\u00e0","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02358-7","article-title":"TNF\u03b1 blockade overcomes resistance to anti-PD-1 in experimental melanoma","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.mam.2024.101318_bib14","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.mam.2024.101318_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SPC.0000000000000457","article-title":"From cachexia to obesity: the role of host metabolism in cancer immunotherapy","volume":"13","author":"Brocco","year":"2019","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.mam.2024.101318_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.54095","article-title":"Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer","volume":"9","author":"Burfeind","year":"2020","journal-title":"Elife"},{"issue":"14","key":"10.1016\/j.mam.2024.101318_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143615","article-title":"Chemotherapy-induced myopathy: the dark side of the cachexia sphere","volume":"13","author":"Campelj","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.mam.2024.101318_bib18","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.4049\/jimmunol.1302801","article-title":"Oxidized lipids block antigen cross-presentation by dendritic cells in cancer","volume":"192","author":"Cao","year":"2014","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2024.101318_bib19","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1054\/bjoc.2000.1299","article-title":"Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats","volume":"83","author":"Carb\u00f3","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mam.2024.101318_bib20","article-title":"Spermidine - an old molecule with a new age-defying immune function","author":"Chamoto","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.mam.2024.101318_bib21","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ymthe.2022.01.025","article-title":"Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells","volume":"30","author":"Chaturvedi","year":"2022","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.mam.2024.101318_bib22","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/1078-0432.CCR-10-3126","article-title":"PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine","volume":"17","author":"Cheever","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.mam.2024.101318_bib23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/jcsm.12538","article-title":"Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma","volume":"11","author":"Chu","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.mam.2024.101318_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/805172","article-title":"Role of inflammation in muscle homeostasis and myogenesis","volume":"2015","author":"Costamagna","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.mam.2024.101318_bib25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/jcsm.12539","article-title":"Interleukin-4 administration improves muscle function, adult myogenesis, and lifespan of colon carcinoma-bearing mice","volume":"11","author":"Costamagna","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.mam.2024.101318_bib26","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1172\/JCI116897","article-title":"Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model","volume":"92","author":"Costelli","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.mam.2024.101318_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/S0304-3835(03)00415-4","article-title":"Reduced protein degradation rates and low expression of proteolytic systems support skeletal muscle hypertrophy in transgenic mice overexpressing the c-ski oncogene","volume":"200","author":"Costelli","year":"2003","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.mam.2024.101318_bib28","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.00104.2006","article-title":"IGF-1 is downregulated in experimental cancer cachexia","volume":"291","author":"Costelli","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"12","key":"10.1016\/j.mam.2024.101318_bib29","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.4049\/jimmunol.1302895","article-title":"Novel role for tumor-induced expansion of myeloid-derived cells in cancer cachexia","volume":"192","author":"Cuenca","year":"2014","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2024.101318_bib30","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3945\/ajcn.2008.27025","article-title":"Cancer cachexia is associated with the IL10 \u22121082 gene promoter polymorphism in patients with gastroesophageal malignancy","volume":"89","author":"Deans","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"issue":"22","key":"10.1016\/j.mam.2024.101318_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13225767","article-title":"Activation of the complement system in patients with cancer cachexia","volume":"13","author":"Deng","year":"2021","journal-title":"Cancers"},{"issue":"7501","key":"10.1016\/j.mam.2024.101318_bib32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature13193","article-title":"The role of senescent cells in ageing","volume":"509","author":"Van Deursen","year":"2014","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.mam.2024.101318_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121893","article-title":"Depleting Ly6G positive myeloid cells reduces pancreatic cancer-induced skeletal muscle atrophy","volume":"11","author":"Deyhle","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.mam.2024.101318_bib34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jcsm.12029","article-title":"Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients","volume":"6","author":"van Dijk","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.mam.2024.101318_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41577-019-0236-2","article-title":"Do haematopoietic stem cells age?","volume":"20","author":"Dorshkind","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.mam.2024.101318_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219060","article-title":"Neutrophil-to-lymphocyte ratio evolution is an independent predictor of early progression of second-line nivolumab-treated patients with advanced non-small-cell lung cancers","volume":"14","author":"Dusselier","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mam.2024.101318_bib37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4049\/jimmunol.2200064","article-title":"Activin A-expressing polymorphonuclear myeloid-derived suppressor cells infiltrate skeletal and cardiac muscle and promote cancer cachexia","volume":"211","author":"Dzierlega","year":"2023","journal-title":"J. Immunol."},{"issue":"6445","key":"10.1016\/j.mam.2024.101318_bib38","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.289.6445.584","article-title":"Protein synthesis in muscle measured in vivo in cachectic patients with cancer","volume":"289","author":"Emery","year":"1984","journal-title":"Br. Med. J."},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MCO.0000000000000236","article-title":"Protein anabolic resistance in cancer","volume":"19","author":"Engelen","year":"2016","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MCO.0000000000000236","article-title":"Protein anabolic resistance in cancer","volume":"19","author":"Engelen","year":"2016","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"5","key":"10.1016\/j.mam.2024.101318_bib41","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/jcsm.12450","article-title":"Macrophages protect against loss of adipose tissue during cancer cachexia","volume":"10","author":"Erdem","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.mam.2024.101318_bib42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1515\/mr-2022-0047","article-title":"Progress in nanoparticle-based regulation of immune cells","volume":"3","author":"Fan","year":"2021","journal-title":"Medical review"},{"issue":"5","key":"10.1016\/j.mam.2024.101318_bib43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol [Internet]"},{"key":"10.1016\/j.mam.2024.101318_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584509","article-title":"Monitoring of the complement system status in patients with B-cell malignancies treated with rituximab","volume":"11","author":"Felberg","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.mam.2024.101318_bib45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.mam.2024.101318_bib46","article-title":"Biomarkers of cellular senescence predict the onset of mobility disability and are reduced by physical activity in older adults","author":"Fielding","year":"2023","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"10.1016\/j.mam.2024.101318_bib47","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.molmed.2017.03.001","article-title":"Connecting the metabolic and immune responses to cancer","volume":"23","author":"Flint","year":"2017","journal-title":"Trends Mol. Med."},{"issue":"10","key":"10.1016\/j.mam.2024.101318_bib48","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/s43587-021-00121-8","article-title":"Strategies for targeting senescent cells in human disease","volume":"1","author":"Gasek","year":"2021","journal-title":"Nat Aging"},{"issue":"5","key":"10.1016\/j.mam.2024.101318_bib49","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ni.2588","article-title":"Understanding immunosenescence to improve responses to vaccines","volume":"14","author":"Goronzy","year":"2013","journal-title":"Nat. Immunol."},{"issue":"36","key":"10.1016\/j.mam.2024.101318_bib50","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.1039\/D3TB01358H","article-title":"Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies","volume":"11","author":"Guo","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-39817-3","article-title":"Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment","volume":"14","author":"Haake","year":"2023","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.mam.2024.101318_bib52","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jcsm.12167","article-title":"Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016","volume":"7","author":"von Haehling","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-022-00466-3","article-title":"Single-cell sequencing unveils key contributions of immune cell populations in cancer-associated adipose wasting","volume":"8","author":"Han","year":"2022","journal-title":"Cell Discov"},{"issue":"3","key":"10.1016\/j.mam.2024.101318_bib54","first-page":"1076","article-title":"Attenuation of resting but not load-mediated protein synthesis in prostate cancer patients on androgen deprivation","volume":"102","author":"Hanson","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.mam.2024.101318_bib55","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI68523","article-title":"NF-\u03baB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia","volume":"123","author":"He","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.mam.2024.101318_bib56","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib57","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.043166","article-title":"HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia","volume":"13","author":"Huot","year":"2020","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.mam.2024.101318_bib58","volume":"vol. 13","author":"Inaba","year":"2018"},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12964-023-01424-6","article-title":"Macrophage barrier in the tumor microenvironment and potential clinical applications","volume":"22","author":"Ji","year":"2024","journal-title":"Cell Commun. Signal."},{"issue":"6","key":"10.1016\/j.mam.2024.101318_bib60","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.cell.2015.08.031","article-title":"Targeting of Fn14 prevents cancer-induced cachexia and prolongs survival","volume":"162","author":"Johnston","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.mam.2024.101318_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9894238","article-title":"Kynurenine, a tryptophan metabolite that increases with age, induces muscle atrophy and lipid peroxidation","author":"Kaiser","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"13","key":"10.1016\/j.mam.2024.101318_bib62","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2024.101318_bib63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2017.04.013","article-title":"Cellular senescence: a translational perspective","volume":"21","author":"Kirkland","year":"2017","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.mam.2024.101318_bib64","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MCO.0b013e328351c3fc","article-title":"TWEAK and TRAF6 regulate skeletal muscle atrophy","volume":"15","author":"Kumar","year":"2012","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"2","key":"10.1016\/j.mam.2024.101318_bib65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.immuni.2016.01.009","article-title":"Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent accumulation of regulatory T cells","volume":"44","author":"Kuswanto","year":"2016","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.mam.2024.101318_bib66","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jcsm.12417","article-title":"Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention","volume":"10","author":"Li","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.mam.2024.101318_bib67","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3892\/mmr.2014.2230","article-title":"Complement component 3 is a prognostic factor of non-small cell lung cancer","volume":"10","author":"Lin","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.mam.2024.101318_bib68","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1016\/j.ymthe.2021.06.001","article-title":"Bifunctional TGF-\u03b2 trap\/IL-15 protein complex elicits potent NK cell and CD8+ T cell immunity against solid tumors","volume":"29","author":"Liu","year":"2021","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib69","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cmet.2022.11.001","article-title":"Meta-hallmarks of aging and cancer","volume":"35","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mam.2024.101318_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155522","article-title":"The dual role of complement in cancers, from destroying tumors to promoting tumor development","volume":"143","author":"Lu","year":"2021","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.mam.2024.101318_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041076","article-title":"Effect of cancer-related cachexia and associated changes in nutritional status, inflammatory status, and muscle mass on immunotherapy efficacy and survival in patients with advanced non-small cell lung cancer","volume":"15","author":"Madeddu","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.mam.2024.101318_bib72","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cell.2005.09.022","article-title":"TWEAK attenuates the transition from innate to adaptive immunity","volume":"123","author":"Maecker","year":"2005","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.mam.2024.101318_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277708","article-title":"Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1\/PD-L1 inhibitors","volume":"18","author":"Makrakis","year":"2023","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.mam.2024.101318_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12113221","article-title":"Marked increased production of acute phase reactants by skeletal muscle during cancer cachexia","volume":"12","author":"Massart","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.mam.2024.101318_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12226","article-title":"The mitochondrial metabolic reprogramming agent trimetazidine as an \u2018exercise mimetic\u2019 in cachectic C26-bearing mice","volume":"8","author":"Molinari","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"10","key":"10.1016\/j.mam.2024.101318_bib76","first-page":"669","article-title":"FDA approves first CAR T therapy","volume":"16","author":"Mullard","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mam.2024.101318_bib77","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ebiom.2019.10.034","article-title":"Skeletal muscle as potential central link between sarcopenia and immune senescence","volume":"49","author":"Nelke","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mam.2024.101318_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101840","article-title":"Beyond youth: understanding CAR T cell fitness in the context of immunological aging","volume":"70","author":"Noll","year":"2023","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22361-3","article-title":"Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia","volume":"12","author":"Olson","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.mam.2024.101318_bib80","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1158\/2326-6066.CIR-23-0121","article-title":"Considerations and approaches for cancer immunotherapy in the aging host","volume":"11","author":"Ontiveros","year":"2023","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.mam.2024.101318_bib81","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.devcel.2018.05.026","article-title":"Twist1 activation in muscle progenitor cells causes muscle loss akin to cancer cachexia","volume":"45","author":"Parajuli","year":"2018","journal-title":"Dev. Cell"},{"issue":"7","key":"10.1016\/j.mam.2024.101318_bib82","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/ijc.25146","article-title":"Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?","volume":"127","author":"Penna","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.mam.2024.101318_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013604","article-title":"Muscle wasting and impaired Myogenesis in tumor bearing mice are prevented by ERK inhibition","volume":"5","author":"Penna","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.mam.2024.101318_bib84","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1089\/ars.2020.8041","article-title":"The redox balance: a target for interventions against muscle wasting in cancer cachexia?","volume":"33","author":"Penna","year":"2020","journal-title":"Antioxidants Redox Signal."},{"issue":"4","key":"10.1016\/j.mam.2024.101318_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040963","article-title":"Early neutrophilia marked by aerobic glycolysis sustains host metabolism and delays cancer cachexia","volume":"14","author":"Petruzzelli","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2024.101318_bib86","first-page":"67","article-title":"Anti-cytokines in the treatment of cancer cachexia","volume":"vol. 8","author":"Prado","year":"2019"},{"issue":"4","key":"10.1016\/j.mam.2024.101318_bib87","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3945\/ajcn.113.060228","article-title":"Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?","volume":"98","author":"Prado","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.mam.2024.101318_bib88","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jcsm.13152","article-title":"Association between physical activity, growth differentiation factor 15 and bodyweight in older adults: a longitudinal mediation analysis","volume":"14","author":"Raffin","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.mam.2024.101318_bib89","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/2326-6066.CIR-22-0487","article-title":"Influence of adipose tissue distribution, sarcopenia, and nutritional status on clinical outcomes after CD19 CAR T-cell therapy","volume":"11","author":"Rejeski","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.mam.2024.101318_bib90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2020.03.003","article-title":"Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors","volume":"143","author":"Roch","year":"2020","journal-title":"Lung Cancer"},{"issue":"21","key":"10.1016\/j.mam.2024.101318_bib91","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.20.00611","article-title":"Management of cancer cachexia: ASCO guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.mam.2024.101318_bib92","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjh.18054","article-title":"Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma","volume":"197","author":"Roy","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"605","key":"10.1016\/j.mam.2024.101318_bib93","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay9592","article-title":"Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia","volume":"13","author":"Sartori","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"23","key":"10.1016\/j.mam.2024.101318_bib94","doi-asserted-by":"crossref","first-page":"23497","DOI":"10.18632\/aging.202200","article-title":"Pharmacological blockade of TNF\u03b1 prevents sarcopenia and prolongs survival in aging mice","volume":"12","author":"Sciorati","year":"2020","journal-title":"Aging"},{"issue":"15","key":"10.1016\/j.mam.2024.101318_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153806","article-title":"The complement system in ovarian cancer: an underexplored old path","volume":"13","author":"Senent","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.mam.2024.101318_bib96","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.mam.2024.101318_bib97","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13806","article-title":"Immunotherapeutic approach to reduce senescent cells and alleviate senescence-associated secretory phenotype in mice","volume":"22","author":"Shrestha","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.mam.2024.101318_bib98","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","article-title":"Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia","volume":"64","author":"Siddiqui","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"issue":"12","key":"10.1016\/j.mam.2024.101318_bib99","doi-asserted-by":"crossref","first-page":"9833","DOI":"10.3390\/curroncol29120773","article-title":"Complement and fungal dysbiosis as prognostic markers and potential targets in PDAC treatment","volume":"29","author":"Speth","year":"2022","journal-title":"Curr. Oncol."},{"issue":"4","key":"10.1016\/j.mam.2024.101318_bib100","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41423-020-00556-w","article-title":"Implications of metabolism-driven myeloid dysfunctions in cancer therapy","volume":"18","author":"Strauss","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.mam.2024.101318_bib101","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/emmm.201200231","article-title":"P-selectin genotype is associated with the development of cancer cachexia","volume":"4","author":"Tan","year":"2012","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.mam.2024.101318_bib102","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nri.2016.150","article-title":"Regulation of muscle growth and regeneration by the immune system","volume":"17","author":"Tidball","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.mam.2024.101318_bib103","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1158\/0008-5472.CAN-18-1544","article-title":"Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells","volume":"79","author":"Travelli","year":"2019","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.mam.2024.101318_bib104","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3892\/ijo.2013.1998","article-title":"Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model","volume":"43","author":"Tzika","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.mam.2024.101318_bib105","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.957994","article-title":"Trial watch: Ido inhibitors in cancer therapy","volume":"3","author":"Vacchelli","year":"2014","journal-title":"OncoImmunology"},{"issue":"5","key":"10.1016\/j.mam.2024.101318_bib106","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3945\/ajcn.116.140434","article-title":"Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapy","volume":"105","author":"Vazeille","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.mam.2024.101318_bib107","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.mam.2024.101318_bib108","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41591-018-0054-2","article-title":"Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.mam.2024.101318_bib109","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nm.3961","article-title":"Excess TGF-\u03b2 mediates muscle weakness associated with bone metastases in mice","volume":"21","author":"Waning","year":"2015","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.mam.2024.101318_bib110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/0148607108325075","article-title":"Myeloid-derived suppressor cells in cancer cachexia syndrome: a new explanation for an old problem","volume":"32","author":"Winfield","year":"2008","journal-title":"JPEN - J. Parenter. Enter. Nutr."},{"key":"10.1016\/j.mam.2024.101318_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00951","article-title":"Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint","volume":"11","author":"Wischhusen","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2024.101318_bib112","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.ajpath.2011.06.028","article-title":"Signal transducer and activator of transcription 3 (Stat3C) promotes myeloid-derived suppressor cell expansion and immune suppression during lung tumorigenesis","volume":"179","author":"Wu","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.mam.2024.101318_bib113","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","article-title":"Senolytics improve physical function and increase lifespan in old age","volume":"24","author":"Xu","year":"2018","journal-title":"Nat. Med."},{"issue":"709","key":"10.1016\/j.mam.2024.101318_bib114","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add1951","article-title":"NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates","volume":"15","author":"Yang","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mam.2024.101318_bib115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.clnesp.2018.11.005","article-title":"Prevalance of sarcopenia according to decade","volume":"29","author":"Yazar","year":"2019","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.mam.2024.101318_bib116","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5737159","article-title":"Enavatuzumab, a humanized anti-TWEAK receptor monoclonal antibody, exerts antitumor activity through attracting and activating innate immune effector cells","author":"Ye","year":"2017","journal-title":"J Immunol Res"}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299724000773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299724000773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T01:13:13Z","timestamp":1733361193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299724000773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":116,"alternative-id":["S0098299724000773"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2024.101318","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulation: A new approach to cancer cachexia, potentially suitable for aging","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2024.101318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101318"}}